Source link : https://www.newshealth.biz/health-news/nccrt-wins-in-escc-trial/
SAN DIEGO — Neoadjuvant concurrent chemoradiotherapy significantly improves survival outcomes over adjuvant sequential chemoradiotherapy (ASCRT) in patients with locally advanced esophageal squamous cell carcinoma, confirmed the first randomized trial to directly compare the two approaches. Yaoyao Zhu, MD, Department of Radiation Oncology, Shanghai Pulmonary Hospital, Shanghai, China, presented the new research at the IASLC World […]
Author : News Health
Publish date : 2024-10-01 10:49:07
Copyright for syndicated content belongs to the linked Source.